blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2432779

EP2432779 - BENZOXAZEPINES BASED P13K/MTOR INHIBITORS AGAINST PROLIFERATIVE DISEASES [Right-click to bookmark this link]
Former [2012/13]BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES
[2014/13]
StatusThe application is deemed to be withdrawn
Status updated on  12.12.2014
Database last updated on 03.10.2024
Most recent event   Tooltip12.12.2014Application deemed to be withdrawnpublished on 14.01.2015  [2015/03]
Applicant(s)For all designated states
Exelixis, Inc.
210 East Grand Avenue P.O. Box 511
South San Francisco, CA 94083-0511 / US
[2012/13]
Inventor(s)01 / ANAND, Neel, Kumar
977 El Camino Real
Unit 303
Burlingame, CA 94010 / US
02 / BLAZEY, Charles, M.
171 Randall Street
South San Francisco, CA 94131 / US
03 / BOWLES, Owen, Joseph
1066 Manzanita Drive
Pacifica, CA 94044 / US
04 / BUHR, Chris, Allen
355 Belmont Avenue
Redwood City, CA 94061 / US
05 / BUSSENIUS, Joerg
223 Bonita Lane
Foster City, CA 94404 / US
06 / CURTIS, Jeffry, Kimo
310 Redwood Road
San Anselmo, CA 94960 / US
07 / DEFINA, Steven, Charles
1232 Floribunda Avenue 6
Burlingame, CA 94010 / US
08 / DUBENKO, Larisa
584 46th Avenue
San Francisco, CA 94121 / US
09 / HARRIS, Jason, R.
3130 College Drive
San Bruno, CA 94066 / US
10 / JACKSON-UGUETO, Eileen
641 Stanford Avenue
Palo Alto, CA 94306 / US
11 / JOSHI, Anagha
36340 Easterday Way
Fremont, CA 94536 / US
12 / KIM, Angie, Inyoung
928 Shoal Drive
San Mateo, CA 94404 / US
13 / TSUHAKO, Amy, Lew
1232 Madruga Way
Milpitas, CA 95035 / US
14 / MA, Sunghoon
802 Spruance Lane
Foster City, CA 94404 / US
15 / MANALO, Jean-claire, Limun
4159 Callan Boulevard
Daly City, CA 94015 / US
16 / NG, Stephanie
267 Curtner Avenue 25
Palo Alto, CA 94306 / US
17 / PETO, Csaba, J.
9 Christensen Court
Alameda, CA 94502 / US
18 / RICE Kenneth D.
444 Montecillo Road
San Rafael, CA 94903 / US
19 / TSANG, Tsze, H.
8367 Kent Drive
El Cerrito, CA 94530 / US
20 / ZAHARIA, Cristiana, A.
644 Topaz Street
Redwood City, CA 94061 / US
 [2012/13]
Representative(s)Main, Malcolm Charles
Murgitroyd & Company
Immeuble Atlantis
55 Allee Pierre Ziller
06560 Valbonne - Sophia Antipolis / FR
[N/P]
Former [2012/13]Main, Malcolm Charles
Murgitroyd & Company Immeuble Atlantis 55 Allee Pierre Ziller
06560 Valbonne - Sophia Antipolis / FR
Application number, filing date10731844.620.05.2010
WO2010US35565
Priority number, dateUS20090216980P22.05.2009         Original published format: US 216980 P
[2012/13]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2010135524
Date:25.11.2010
Language:EN
[2010/47]
Type: A1 Application with search report 
No.:EP2432779
Date:28.03.2012
Language:EN
The application published by WIPO in one of the EPO official languages on 25.11.2010 takes the place of the publication of the European patent application.
[2012/13]
Search report(s)International search report - published on:EP25.11.2010
ClassificationIPC:C07D413/04, C07D413/14, C07D417/14, C07D471/04, C07D471/14, C07D487/04, C07D487/08, C07D495/04, C07D498/04, C07D513/04, C07D519/00, A61P35/00, A61K31/553
[2012/13]
CPC:
C07D413/14 (EP,KR,US); A61K31/553 (KR); A61P35/00 (EP);
A61P35/02 (EP); A61P35/04 (EP); A61P43/00 (EP);
C07D413/04 (EP,KR,US); C07D417/14 (EP,US); C07D471/04 (EP,US);
C07D471/14 (EP,US); C07D487/04 (EP,US); C07D487/08 (EP,US);
C07D495/04 (EP,US); C07D498/04 (EP,US); C07D513/04 (EP,US);
C07D519/00 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   SM,   TR [2012/13]
Extension statesBA21.12.2011
RS21.12.2011
TitleGerman:AUF BENZOXAZEPINEN BASIERENDE P13K/MT0R-HEMMER GEGEN PROLIFERATIVE ERKRANKUNGEN[2012/13]
English:BENZOXAZEPINES BASED P13K/MTOR INHIBITORS AGAINST PROLIFERATIVE DISEASES[2014/13]
French:INHIBITEURS DE PI3K/MTOR À BASE DE BENZOXAZÉPINES POUR LUTTER CONTRE LES MALADIES PROLIFÉRATIVES[2012/13]
Former [2012/13]BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES
Entry into regional phase21.12.2011National basic fee paid 
21.12.2011Designation fee(s) paid 
21.12.2011Examination fee paid 
Examination procedure21.12.2011Examination requested  [2012/13]
01.08.2012Amendment by applicant (claims and/or description)
20.06.2013Despatch of a communication from the examining division (Time limit: M04)
30.10.2013Reply to a communication from the examining division
03.03.2014Communication of intention to grant the patent
15.07.2014Application deemed to be withdrawn, date of legal effect  [2015/03]
21.08.2014Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time  [2015/03]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.06.2013
Fees paidRenewal fee
29.03.2012Renewal fee patent year 03
10.05.2013Renewal fee patent year 04
27.03.2014Renewal fee patent year 05
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]WO2004078733  (VERTEX PHARMA [US], et al) [A] 1-31 * page 258; compound 656 * * page 296; compound 807 * * Use in therapy of pain and cancer pain:; page 544; claim 212 *;
 [A]WO2008108445  (TAKEDA PHARMACEUTICAL [JP], et al) [A] 1-31 * page 178; examples 28,33 *;
 [A]WO2008109599  (WYETH CORP [US], et al) [A] 1-31 * pages 20,52,54; tables 3a,4; compounds Ia-20 * * Use in therapy of cancer:;; claims 16-17 *;
 [A]WO2009042092  (MERCK & CO INC [US], et al) [A] 1-31 * page 47; example 151 ** Use in therapy of cancer:; page 1626 - line 33 *;
 [AP]EP2123644  (TAKEDA PHARMACEUTICAL [JP]) [AP] 1-31 * page 58; examples 28,33 * * Use in therapy of cancer:; page 38, line 18 - line 27 *
by applicant   - CAMPBELL ET AL., CANCER RES, (2004), vol. 64, pages 7678 - 7681
    - LEVINE ET AL., CLIN CANCER RES, (2005), vol. 11, pages 2875 - 2878
    - WANG ET AL., HUM MUTAT, (2005), vol. 25, page 322
    - LEE ET AL., GYNECOL ONCOL, (2005), vol. 97, pages 26 - 34
    - BACHMAN ET AL., CANCER BIOL THER, (2004), vol. 3, pages 772 - 775
    - LI ET AL., BREAST CANCER RES TREAT, (2006), vol. 96, pages 91 - 95
    - SAAL ET AL., CANCER RES, (2005), vol. 65, pages 2554 - 2559
    - SAMUELS; VELCULESCU, CELL CYCLE, (2004), vol. 3, pages 1221 - 1224
    - SAMUELS, SCIENCE, (2004), vol. 304, page 554
    - VCLHO ET AL., EUR J CANCER, (2005), vol. 41, pages 1649 - 1654
    - ODA ET AL., CANCER RES., (2005), vol. 65, pages 10669 - 10673
    - BYUN ET AL., INT J CANCER, (2003), vol. 104, pages 318 - 327
    - LEE ET AL., ONCOGENE, (2005), vol. 24, pages 1477 - 1480
    - TANG ET AL., LUNG CANCER, (2006), vol. 51, pages 181 - 191
    - MASSION ET AL., AM J RESPIR CRIT CARE MED, (2004), vol. 170, pages 1088 - 1094
    - WU ET AL., J CLIN ENDOCRINOL METAB, (2005), vol. 90, pages 4688 - 4693
    - SUJOBERT ET AL., BLOOD, (1997), vol. 106, pages 1063 - 1066
    - HICKEY; COTTER, J BIOL CHEM, (2006), vol. 281, pages 2441 - 2450
    - HARTMANN ET AL., ACTA NEUROPATHOL (BERL), (2005), vol. 109, pages 639 - 642
    - BJORNSTI; HOUGHTON, REV CANCER, (2004), vol. 4, no. 5, pages 335 - 48
    - HOUGHTON; HUANG, MICROBIOL IMMUNOL, (2004), vol. 279, pages 339 - 59
    - INOKI; CORRADETTI ET AL., NAT GENET, (2005), vol. 37, no. 1, pages 19 - 24
    - NAGATA, LAN ET AL., CANCER CELL, (2004), vol. 6, no. 2, pages 117 - 27
    - PANDOLFI, NENGL J MED, (2004), vol. 351, no. 22, pages 2337 - 8
    - NAHTA, YU ET AL., NAT CLIN PRACT ONCOL, (2006), vol. 3, no. 5, pages 269 - 280
    - DAL COL, ZANCAI ET AL., BLOOD, (2008), vol. 111, no. 10, pages 5142 - 51
    - THOMAS, TRAN ET AL., NAT MED, (2006), vol. 12, no. 1, pages 122 - 7
    - ATKINS, HIDALGO ET AL., J CLIN ONCOL, (2004), vol. 22, no. 5, pages 909 - 18
    - MOTZER, HUDES ET AL., J CLIN ONCOL, (2007), vol. 25, no. 25, pages 3958 - 64
    - SUJOBCRT, BARDCT ET AL., BLOOD, (2005), vol. 106, no. 3, pages 1063 - 6
    - BILLOTTET, GRANDAGE ET AL., ONCOGENE, (2006), vol. 25, no. 50, pages 6648 - 6659
    - TAMBURINI, ELIE ET AL., BLOOD, (2007), vol. 110, no. 3, pages 1025 - 8
    - SKORSKI, BELLACOSA ET AL., EMBO J, (1997), vol. 16, no. 20, pages 6151 - 61
    - BAI, OUYANG ET AL., BLOOD, (2000), vol. 96, no. 13, pages 4319 - 27
    - HICKEY; COTTER, BIOL CHEM, (2006), vol. 281, no. 5, pages 2441 - 50
    - UDDIN, HUSSAIN ET AL., BLOOD, (2006), vol. 108, no. 13, pages 4178 - 86
    - HERNANDO, CHARYTONOWICZ ET AL., NAT MED, (2007), vol. 13, no. 6, pages 748 - 53
    - WAN; HELMAN, ONCOLOGIST, (2007), vol. 12, no. 8, pages 1007 - 18
    - CAO, YU ET AL., CANCER RES, (2008), vol. 68, no. 19, pages 8039 - 8048
    - WAN, SHEN ET AL., NEOPLASIA, (2006), vol. 8, no. 5, pages 394 - 401
    - SHAYESTEH, LU ET AL., NAT GENET, (1999), vol. 21, no. 1, pages 99 - 102
    - LEE, CHOI ET AL., GYNECOL ONCOL, (2005), vol. 97, no. 1, pages 26 - 34
    - OBATA, MORLAND ET AL., CANCER RES, (1998), vol. 58, no. 10, pages 2095 - 7
    - LU, WU ET AL., CLIN CANCER RES, (2008), vol. 14, no. 9, pages 2543 - 50
    - TANG, HE ET AL., LUNG CANCER, (2006), vol. 51, no. 2, pages 181 - 91
    - MARSIT, ZHENG ET AL., HUM PATHOL, (2005), vol. 36, no. 7, pages 768 - 76
    - MASSION, TAFLAN ET AL., AM J RE.SPIR CRIT CARE MED, (2004), vol. 170, no. 10, pages 1088 - 94
    - KOKUBO, GEMMA ET AL., BR J CANCER, (2005), vol. 92, no. 9, pages 1711 - 9
    - PAO, WANG ET AL., PUB LIBRARY OF SCIENCE MED, (2005), vol. 2, no. 1, page E17
    - VELHO, OLIVEIRA ET AL., EUR J CANCER, (2005), vol. 41, no. 11, pages 1649 - 54
    - FOUKAS, CLARET ET AL., NATURE, (2006), vol. 441, no. 7091, pages 366 - 370
    - GOCL, ARNOLD, CANCER RES, (2004), vol. 64, no. 9, pages 3014 - 21
    - NASSIF, LOBO ET AL., ONCOGENE, (2004), vol. 23, no. 2, pages 617 - 28
    - BOS CANCER RES, (1989), vol. 49, no. 17, pages 4682 - 9
    - FEARON, ANN N Y ACAD SCI, (1995), vol. 768, pages 101 - 10
    - BYUN, CHO ET AL., INT J CANCER, (2003), vol. 104, no. 3, pages 318 - 27
    - LEE, SOUNG ET AL., ONCOGENE, (2005), vol. 24, no. 8, pages 1477 - 80
    - HU, HUANG ET AL., CANCER, (2003), vol. 97, no. 8, pages 1929 - 40
    - WAN, JIANG ET AL., CANCER RES CLIN ONCOL, (2003), vol. 129, no. 2, pages 100 - 6
    - GULDBERG; STRATEN ET AL., CANCER RES, (1997), vol. 57, no. 17, pages 3660 - 3
    - TSAO, ZHANG ET AL., CANCER RES, (2000), vol. 60, no. 7, pages 1800 - 4
    - WHITEMAN, ZHOU ET AL., INT J CANCER, (2002), vol. 99, no. 1, pages 63 - 7
    - GOEL, LAZAR ET AL., J INVEST DERMATOL, (2006), vol. 126, no. L, pages 154 - 60
    - ASANO, YAO ET AL., ONCOGENE, (2004), vol. 23, no. 53, pages 8571 - 80
    - CAIRNS, OKAMI ET AL., CANCER RES, (1997), vol. 57, no. 22, pages 4997 - 5000
    - GRAY, STEWART ET AL., BR J CANCER, (1998), vol. 78, no. 10, pages 1296 - 300
    - WANG, PARSONS ET AL., CLIN CANCER RES, (1998), vol. 4, no. 3, pages 811 - 5
    - WHANG, WU ET AL., PROC NATL ACAD SCI U S A, (1998), vol. 95, no. 9, pages 5246 - 50
    - MAJUMDER; SELLERS, ONCOGENE, (2005), vol. 24, no. 50, pages 7465 - 74
    - WANG, GARCIA ET AL., PROC NATL ACAD SCI USA, (2006), vol. 103, no. 5, pages 1480 - 5
    - LU, REN ET AL., INTJ ONCOL, (2006), vol. 28, no. L, pages 245 - 51
    - MULHOLLAND, DEDHAR ET AL., ONCOGENE, (2006), vol. 25, no. 3, pages 329 - 37
    - XIN, TEITELL ET AL., PROC NATL ACAD SCI U S A, vol. 03, no. 20, pages 7789 - 94
    - MIKHAILOVA, WANG ET AL., ADV EXP MED BIOL, (2008), vol. 617, pages 397 - 405
    - WANG, MIKHAILOVA, ONCOGENE, (2008), vol. 27, no. 56, pages 7106 - 7117
    - GARCIA-ROSTAN, COSTA ET AL., CANCER RES, (2005), vol. 65, no. 22, pages 10199 - 207
    - WU, MAMBO ET AL., J CLIN ENDOCRINOL METAB, (2005), vol. 90, no. 8, pages 4688 - 93
    - BISSLER, MCCORMACK ET AL., N ENGL J MED., (2008), vol. 358, no. 2, pages 140 - 151
    - RANDA M. S, AMIN PATHOLOGY INTERNATIONAL, (2008), vol. 58, no. 1, pages 38 - 44
    - GUPTA, MCKENNA ET AL., CLIN CANCER RES, (2002), vol. 8, no. 3, pages 885 - 892
    - FERNER, EUR JHUM GENET, (2006), vol. 15, no. 2, pages 131 - 138
    - SABATINI, NAT REV CANCER, (2006), vol. 6, no. 9, pages 729 - 734
    - JOHANNESSEN, JOHNSON ET AL., CURRENT BIOLOGY, (2008), vol. 18, no. 1, pages 56 - 62
    - S. M. BERGE ET AL., "Pharmaceutical Salts", J. PHARM. SCI., (1977), vol. 66, pages 1 - 19
    - J. OF MED. CHEM., (2004), vol. 47, no. 12, pages 3163 - 3179
    - J. ORG. CHEM., (2001), vol. 66, no. 8, pages 2784 - 2788
    - J. MED. CHEM., (1992), vol. 35, no. 14, pages 2703 - 10
    - J. MED. CHEM., (1983), vol. 26, no. 3, pages 420 - 5
    - J. CHEM. SOC. PERKIN TRANS, (1987), vol. 1, no. 7, pages 1485 - 8
    - HETEROCYCLES, (1999), vol. 50, no. 2, pages 867 - 874
    - J. ORG. CHEM., (1991), vol. 56, no. 21, pages 6199 - 205
    - J. MED. CHEM., (1987), vol. 30, pages 1177 - 1186
    - J. AM. CHEM. SOC., (1994), vol. 116, pages 2902 - 2913
    - ORG. LCTT., (2003), vol. 5, pages 97 - 99
    - J. ORG. CHEM., (1981), vol. 46, pages 1515 - 1521
    - TETRAHEDRON: ASYMMETRY, (1997), vol. 8, pages 1253 - 1257
    - J. AM. CHEM. SOC., (1974), vol. 96, pages 2121 - 2129
    - J. BIOORG. MED. CHEM., (2007), pages 1106 - 1116
    - BIOORG. AND MED. CHEM. LETT., (2003), vol. 13, pages 2485 - 2488
    - MONATSHEFTE FUER CHEMIE, (1983), vol. 114, no. 6-7, pages 789 - 98
    - SYNTHESIS, (2003), vol. 11, pages 1649 - 1652
    - ELARIDI ET AL., TETRAHEDRON: ASYMMETRY, (2005), vol. 16, no. 7, pages 1309 - 1319
    - CAN. J. CHEM., (1981), vol. 59, pages 601 - 608
    - JOURNAL OF MEDICINAL CHEMISTRY, (2002), vol. 45, no. 3, pages 721 - 739
    - J. HETEROCYCLIC CHEM., (2003), vol. 40, page 261
    - TETRAHEDRON LETTERS, (2000), vol. 41, no. 38, pages 7337 - 7340
    - BIOORG. MED. CHEM. LETT., (2007), vol. 17, no. 19, pages 5406 - 5409
    - JOURNAL OF HETEROCYCLIC CHEMISTRY (200), vol. 40, no. 2, pages 621 - 628
    - JOURNAL OF HETEROCYCLIC CHEMISTRY, (2003), vol. 40, pages 261 - 268
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.